Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net income	$ 22,059	$ 15,043
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	5,051	1,927
Depreciation, amortization and accretion, net	6,241	5,592
Life Insurance, Corporate or Bank Owned, Change in Value	(844)	(384)
Stock-based compensation expense	300	268
Gains on investment securities, net	(589)	(1,130)
Loss (gain) on sales of other real property owned, net	349	(5)
Gain (Loss) on Disposition of Property Plant Equipment	0	653
Loss on write down of fixed assets	337	26
Gains on sale of loans held for sale, net	(809)	(805)
Decrease in accrued interest receivable	(323)	(347)
Increase (decrease) in accrued interest payable	38	(36)
Origination of loans held for sale	(45,076)	(57,199)
Proceeds from sale of loans held for sale	44,981	55,388
Decrease (increase) in other assets	2,475	(2,713)
Decrease in other liabilities	(1,421)	(1,036)
Net cash provided by operating activities	32,769	15,242
Cash flows from investing activities:
Proceeds from maturities of certificates of deposit investments	12,958	13,618
Purchases of certificates of deposit investments	0	12,958
Proceeds from sales of securities available-for-sale	96,184	68,726
Purchases of securities held-to-maturity	0	91,899
Proceeds from maturities of securities available-for-sale	52,894	55,500
Purchases of securities available-for-sale	(134,807)	(84,102)
Purchases of securities held-to-maturity	0	(71,557)
Net increase in loans	(49,198)	(84,432)
Proceeds from Sale of Property, Plant, and Equipment	0	147
Purchases of premises and equipment	(1,304)	(449)
Proceeds from sales of other real property owned	5,356	488
Payments to Acquire Life Insurance Policies	0	(25,000)
Cash Acquired from Acquisition	0	36,774
Net cash used in investing activities	(17,917)	(11,346)
Cash flows from financing activities:
Net decrease in deposits	(112,410)	(3,996)
Increase in federal funds purchased	(20,000)	0
Decrease in repurchase agreements	(69,403)	(24,673)
Proceeds from FHLB advances	52,000	20,000
Repayment of FHLB advances	5,000	5,000
Proceeds from Short-term Debt	0	7,000
Proceeds from Issuance of Long-term Debt	0	15,000
Repayment of other debt	6,813	0
Proceeds from issuance of common stock	4,195	97
Payments of Stock Issuance Costs	(213)	(230)
Dividends paid on preferred stock	0	1,286
Dividends paid on common stock	3,467	3,555
Net cash (used in) provided by financing activities	(121,111)	3,357
(Decrease) increase in cash and cash equivalents	(106,259)	7,253
Cash and cash equivalents at beginning of period	175,902	115,784
Cash and cash equivalents at end of period	69,643	123,037
Cash paid during the period for:
Interest	4,627	2,568
Income taxes	7,969	9,335
Supplemental disclosures of noncash investing and financing activities
Loans Transferred to Other Real Estate Owned	5,317	115
Dividends reinvested in common stock	527	1,052
Net tax benefit related to option and deferred compensation plans	$ 221	140
Supplemental disclosure of purchase of capital stock of First Clover Leaf
Fair value of assets acquired		668,905
Cash paid		22,545
Common stock issued		65,926
Total consideration paid		88,471
Fair value of liabilities assumed		$ 580,434